This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medbox Acquires 50% Of MedVend And Its Patented Technologies

The company has exclusive rights to Patent Number US7689318, an asset now jointly owned by Medbox. A summary of the patent is as follows:

"An inventory control and prescription management and dispensing system including a dispensing vault for storing and dispensing prescriptions in communication with a central computer system which communicates with prescription providers, insurance companies and other third parties. The vault includes robotic means for dispensing pre-filled prescriptions with the aid of RFIDs, barcodes or other means for verifying the medication to be dispensed. The vault uses patient biometrics, a patient registration system, insurance information and doctor information to process the transaction and dispense a specifically labeled pre-filled prescription to the patient."

Medvend enjoys many different revenue streams and benefits, as listed below:

MedVend has 5 main revenue streams:

  1. Sale of fully Automated Medication Dispensing Systems
  2. Sale of Medication
  3. Flat Management fee per dispensed Rx
  4. Marketing Programs on Automated Medication Dispensing Systems
  5. Monetizing anonymous data points through sale of data to Pharmaceutical R & D and marketing companies




Benefits to Medical center, Physician office, Urgent cares, and ER's:
  1. Profit Center for Healthcare facility
  2. Unparalleled convenience to Patients for competitive edge
  3. 100% write off under Tax rule 179 and Tax Code 44
  4. Assist practice in meeting their meaningful use requirement
  5. Assist the Hospital in reducing the attrition rate of patients coming back from standard nursing facilities (SNF's) by obtaining their meds prior to leaving the hospital.




Patient Benefits:

  1. Unparalleled convenience
  2. Competitive Rx cost
  3. Addressing their ailment at the point of care
  4. A higher quality assurance through automation on the prescription fulfillment

The company has already passed beta testing and currently has several machines in the field and is currently working with several large hospital groups to bring this unparalleled level of convenience to patients across the country by the end of 2013.  

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs